887. A Case-Based Discussion of the Treatment and Management of HCV Infection
Session: Meet-the-Professor Session: Hepatitis C: Case-Based Discussion of HCV Treatment in the DAA Era
Friday, October 5, 2018: 7:35 AM
Room: S 214-216
John Scott, MD, FIDSA, Allergy & Infectious Diseases, University of Washington, Seattle, WA

John Scott, MD, MSc is an Associate Professor of Medicine (Division of Allergy and Infectious Diseases) at the University of Washington and Director of the Liver Clinic at Harborview Medical Center. He graduated from Stanford University with a degree in Human Biology, attended Georgetown University School of Medicine cum laude, completed a residency in Internal Medicine at Stanford University Hospitals, and then obtained sub-specialty training in Infectious Diseases at the University of Washington. He serves on the AASLD/IDSA HCV Guideline Committee. He has published in JAMA, Journal of Infectious Diseases, Clinical Infectious Diseases, Annals of Internal Medicine, Nature Medicine and the Lancet. In 2009, he launched Project ECHO in Washington State. This innovative telehealth program helps clinicians serving in rural and underserved areas with the evaluation and treatment of hepatitis C.


J. Scott, Novartis: Scientific Advisor , Consulting fee .

<< Previous Presentation | Next Presentation

Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 3rd with the exception of research findings presented at the IDWeek press conferences.